December 23, 2025 a 11:43 am
COR: Fundamental Ratio Analysis - Cencora, Inc.
Cencora, Inc., formerly AmerisourceBergen Corporation, is a key player in the pharmaceutical distribution industry. With a diversified portfolio of services and a strong market presence, its stock has shown resilience amidst market fluctuations. However, its fundamental evaluation reveals a moderate potential for growth with existing financial ratios indicating specific levels of caution for investors.
Fundamental Rating
Cencora, Inc.'s current fundamental ratings suggest a balanced but cautious approach to its financial health. Here's a detailed look at the current scores and ratings.
| Category | Score | Score Bar |
|---|---|---|
| Discounted Cash Flow (DCF) | 4 | |
| Return on Equity (ROE) | 5 | |
| Return on Assets (ROA) | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
Here is a comparison of Cencora's historical scores to understand its performance over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | 3 | 4 | 5 | 4 | 1 | 1 | 1 |
| Current | 3 | 4 | 5 | 4 | 1 | 1 | 1 |
Analyst Price Targets
The following table presents the analyst's price targets for Cencora, Inc. stock, reflecting both optimistic and cautious outlooks.
| High | Low | Median | Consensus |
|---|---|---|---|
| 415 | 330 | 392 | 375.86 |
Stock chart showcasing Cencora, Inc.'s market performance
Analyst Sentiment
Analyst recommendations for Cencora, Inc. highlight a general consensus towards buying, though some remain cautious.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 31 | |
| Hold | 14 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Cencora, Inc. displays a stable performance in the current market, with its financial metrics indicating moderate potential for growth amidst certain risks. The company's diversified portfolio in healthcare services and international presence remains a strong point. Analyst sentiments are generally positive, suggesting a "Buy". However, potential investors should consider debt-related metrics that may indicate caution, coupled with market dynamics and competition.